https://www.indianpharmapost.com/biocon-biologics-announces-positive-results-from-phase-3-study-of-yesintek-biosimilar-to-ustekinumab-for-chronic-plaque-psoriasis-168712025-03-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/amaran-biotech-signs-mou-with-nippon-fine-chemical-to-expand-cdmo-business-168722025-03-08T00:00:00+05:30always0.9